• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

Month: October 2019

Editor's Choice

Group examines the unique challenges of clinical trials for development of microbiotic medicinal products, including live biotherapeutic products

October 29, 2019 Kristina Campbell

Many individuals living with chronic disease—whether it’s asthma, allergies, atopic dermatitis, type 2 diabetes, or another condition—readily confirm their therapeutic options leave a lot to be desired. Even if an existing drug product deals adequately […]

Pharma & Human Health

Half of all commonly used drugs profoundly affecting the gut microbiome, warn experts

October 26, 2019 Staff Editor

A new study presented at UEG Week 2019 has found that 18 commonly used drug categories extensively affect the taxonomic structure and metabolic potential of the gut microbiome. Eight different categories of drugs were also […]

Editor's Choice

Standardization in microbiome measurements Considerations from sampling to analysis

October 25, 2019 Staff Editor
Pharma & Human Health

Phage lysin stabilizes vaginal microbiome: Phagomed accelerates R&D program against bacterial vaginosis.

October 23, 2019 Staff Editor

Vienna-based biotech company PhagoMed Biopharma GmbH has discovered a novel drug candidate for the treatment of Bacterial Vaginosis and the re-stabilization of the vaginal microbiome. A dedicated R&D team has been established to develop this […]

Editor's Choice

The Lactobacillus Taxonomy change is coming: why, and how to make the most of it?

October 17, 2019 Marco Pane and Nina Vinot

1. What is taxonomy, what’s the reality behind it – and why do we need it anyway? Taxonomy is the branch of science concerned with the classification of organisms. Since Darwin, it has allowed to […]

Editor's Choice

Toward Clinical Utility of Metagenomic Data: Interview with Dr Joël Doré

October 17, 2019 Staff Editor
Finance

Azitra Completes $14 Million Series A Financing

October 16, 2019 Staff Editor

Azitra Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that it has closed a $14 million Series A financing. The financing was led by KdT Ventures in […]

Editor's Choice

5-minute Microbiome Science Roundup: September 2019

October 16, 2019 Kristina Campbell

Through the month of September, the microbiome scientific literature had some particularly interesting contributions related to human health. First up is a pair of papers on the significance of serotonin that’s made in the gut, […]

Finance

BiomeSense Raises $2 Million in Seed Round Funding

October 11, 2019 Staff Editor

BiomeSense, a microbiome startup developing a novel biosensor and analytics platform for daily gut microbiome tracking, announced today that it has closed its $2 million seed funding round. The lead investor was BioX Clan, which […]

Animal Health

Seventure Partners Life Sciences Corporate Update Health for Life: July 2019 – September 2019

October 10, 2019 Staff Editor

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, is pleased to provide an update on its Health for Life investments for the period July 2019 to […]

Pharma & Human Health

Gut bacteria ‘fingerprint’ predicts radiotherapy side effects

October 9, 2019 Staff Editor

Taking a ‘fingerprint’ of the mix of bacteria in the gut can indicate how susceptible individual cancer patients are to gut damage as a result of radiotherapy for prostate and gynaecological cancers, a new study […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

Market Reports
October 26, 2020
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new [...]

Editor’s Choice

  • Why microbiota samples should be collected in all clinical trials?
    January 26, 2021
  • Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
    January 20, 2021
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Market Reports
  • Pharma & Human Health
  • Phytobiome & Environment
  • Premium Content
  • Reports
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter